will analyze already-collected data, to test if topirimate causes birth defects. The antiseizure drug, sold as Topamax by Johnson & Johnson , is a component of a weight-loss drug, Vivus��� Qnexa, that was rejected last year by the FDA in part because of...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Stocks to Watch: Chesapeake, Hartford Financial and Vivus
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account